According to GlobalData’s medical device pipeline database, nine Magnetoencephalographs (MEG) devices are in various stages of development globally. GlobalData’s report Magnetoencephalographs (MEG) provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, eight are in active development, while the remaining two are in an inactive stage of development. There are three products in the early stages of development, and the remaining five are in the late stages of development.

Neurology devices are designed to diagnose, treat, and monitor conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. Magnetoencephalographs (MEG) is a non-invasive functional neuroimaging technique that measures the magnetic fields produced by electrical currents occurring naturally in the brain, using very sensitive magnetometers. Magnetoencephalographs (MEG) also be used to localize brain activity to within a few millimeters. It is a valuable tool for diagnosing and treating neurological disorders, such as epilepsy and stroke. The MEG records and evaluates magnetic fields that result from electrical activity in the brain, which is placed over an image of the brain to identify the location of the activity. MEGs are used to map functional areas (related to motor, language, and memory), as well as identify the precise location of epileptic procedures, aiding in the planning of treatment/intervention for patients.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Magnetoencephalographs (MEG) pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Magnetoencephalographs (MEG) devices. Overall, most of these Magnetoencephalographs (MEG) pipeline devices are being developed by private entities.

Key players involved in the active development of Magnetoencephalographs (MEG) include Aalto University, CEA-Leti, FieldLine, QuSpin, Skolkovo Institute of Science and Technology, University of Nottingham, University College London, University of Houston and York Instruments.

For a complete picture of the developmental pipeline for Magnetoencephalographs (MEG) devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.